Replies to post #18933 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

The good news is a reset just to valuation parity with ADRO puts ADXS at a price of $15 and that's short of consensus fair value for ADXS at around $22. Let's get to valuation parity with ADRO first. Just a matter of time given ADXS' trial data has been stronger than ADRO and we're at a later stage clinically.